Top domestic pharmaceutical companies increased 10% up in sales

As a series of unfavorable factors coincided, such as the governmental drug price restriction and the MERS crisis, weakening of domestic pharmaceutical companies’ management has been suggested, but their external forms have drawn increasing curves for several years already.

A part of the government understands that increasing sales of listed pharmaceutical companies despite various restriction...